STOCK TITAN

ParkerVision permits resale of up to 9.39M shares

PARKERVISION receives no proceeds from resales; it may receive up to $42,620 in gross proceeds if the options are exercised for cash.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
424B3

Rhea-AI Filing Summary

PARKERVISION, INC. (PRKR)'s prospectus permits selling shareholders to resell up to 9,387,500 shares of common stock. The amount includes 2,843,750 shares issued under securities purchase agreements, 6,343,750 shares issuable upon conversion of Convertible Notes or, at the company's option, for interest, and 200,000 shares issuable upon exercise of service-payment options. The Convertible Notes have a fixed conversion price of $0.16 per share.

The company will not receive proceeds from selling-shareholder resales. If the Options are exercised for cash, it will receive up to an aggregate of $42,620 in gross proceeds, which it expects to use for general working capital. At the September 25, 2026 annual meeting, shareholders elected Jeffrey L. Parker as a Class I director and Anthony B. Bowers as a Class II director, and ratified Frazier & Deeter, LLC as the independent registered public accounting firm for the year ending December 31, 2026.

Shares registered for resale 9,387,500 shares Common stock
Shares issued under securities purchase agreements 2,843,750 shares Component of the shares covered by the resale prospectus
Shares issuable upon conversion of Convertible Notes or for interest 6,343,750 shares Component of the shares covered by the resale prospectus
Shares issuable upon exercise of Options 200,000 shares Options issued as payment for services
Fixed conversion price $0.16 per share Convertible Notes
Potential gross proceeds from cash exercise of Options Up to an aggregate of $42,620 Proceeds, if received, are expected to be used for general working capital
Common stock issued and outstanding and entitled to vote 148,226,874 shares As of July 29, 2026
Convertible Notes financial
"shares issuable upon conversion of ... Convertible Notes"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
fixed conversion price financial
"with a fixed conversion price of $0.16 per share"
Broker Non-Vote regulatory
"Broker Non-Vote"
A broker non-vote happens when a brokerage firm holds shares in street name for a client but does not cast a ballot on a particular shareholder item because the broker lacks discretionary authority to vote that matter. Think of it like a person who owns a ticket but the ticket-holder refuses to vote on some issues; the share counts for ownership but not for that vote, which can affect whether proposals reach the required number of votes or a quorum.
record date regulatory
"The record date for shareholders entitled to notice of, and to vote"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
Offering Type secondary
Securities Offered Common Stock
Offering Amount 9,387,500 shares
Use of Proceeds The company will not receive proceeds from selling-shareholder sales. If the Options are exercised for cash, it will receive up to an aggregate of $42,620 in gross proceeds, which it expects to use for general working capital.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PRKR shares are registered for resale?

Selling shareholders may resell up to 9,387,500 shares of common stock. The amount includes 2,843,750 shares issued under securities purchase agreements, 6,343,750 shares issuable upon conversion of Convertible Notes or for interest, and 200,000 shares issuable upon exercise of options.

Will PRKR receive proceeds from the registered share resales?

PARKERVISION will not receive proceeds from selling-shareholder sales. If the Options are exercised for cash, the company will receive up to an aggregate of $42,620 in gross proceeds, which it expects to use for general working capital.

Who did PRKR shareholders elect as directors at the 2026 annual meeting?

Shareholders elected Jeffrey L. Parker as a Class I director, with 21,862,556 votes for and 837,457 withheld, and Anthony B. Bowers as a Class II director, with 22,063,764 votes for and 636,249 withheld. Each election had 71,479,395 broker non-votes.

Did PRKR shareholders ratify its independent accounting firm for 2026?

Shareholders ratified Frazier & Deeter, LLC for the year ending December 31, 2026. The proposal received 93,703,944 votes for, 51,229 against and 424,235 abstentions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

Filed pursuant to Rule 424(b)(3)

Registration No. 333-271351

 

PROSPECTUS SUPPLEMENT No. 39

(to Prospectus dated May 11, 2023)

 

PARKERVISION, INC.

9,387,500 Shares of Common Stock

 

This Prospectus Supplement relates to the prospectus dated May 11, 2023, as amended and supplemented from time to time (the “Prospectus”), which permits the resale by the selling shareholders listed in the Prospectus of up to 9,387,500 shares of our common stock, par value $0.01 per share (“Common Stock”) consisting of (i) an aggregate of 2,843,750 shares of Common Stock issued pursuant to securities purchase agreements dated November 30, 2022, December 23, 2022 and January 13, 2023, (ii) an aggregate of 6,343,750 shares of Common Stock issuable upon conversion of, and for the payment of interest from time to time at our option on, convertible promissory notes dated January 11, 2023 and January 13, 2023 with a fixed conversion price of $0.16 per share (the “Convertible Notes”), and (iii) 200,000 shares of Common Stock issuable upon exercise of options issued as payment for services (“Options”).

 

We will not receive proceeds from the sale of the shares of Common Stock by the selling shareholders. To the extent the Options are exercised for cash, we will receive up to an aggregate of $42,620 in gross proceeds.  We expect to use the proceeds received from the exercise of the Options, if any, for general working capital purposes.

 

This Prospectus Supplement is being filed to update and supplement the information previously included in the Prospectus with the information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on September 28, 2026.  Accordingly, we have attached the 8-K to this prospectus supplement.  You should read this prospectus supplement together with the prospectus, which is to be delivered with this prospectus supplement.

 

Any statement contained in the Prospectus shall be deemed to be modified or superseded to the extent that information in this Prospectus Supplement modifies or supersedes such statement.  Any statement that is modified or superseded shall not be deemed to constitute a part of the Prospectus except as modified or superseded by this Prospectus Supplement.

 

This Prospectus Supplement should be read in conjunction with, and may not be delivered or utilized without, the Prospectus.

 

Our Common Stock is quoted on the OTCQB Venture Market under the ticker symbol “PRKR.”

 

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 6 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or determined whether this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is September 28, 2026.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): September 25, 2026

 

PARKERVISION, INC.

(Exact Name of Registrant as Specified in Charter)

     

Florida

000-22904

59-2971472

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

   

4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida

32207

(Address of Principal Executive Offices)

(Zip Code)

 

(904) 732-6100

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

None

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

Item 5.07 - Submission of Matters to a Vote of Security Holders.

 

The Company held its Annual Meeting of Shareholders (the “Annual Meeting”) on September 25, 2026.  The record date for shareholders entitled to notice of, and to vote at, the Annual Meeting was July 29, 2026.  At the close of business on that date, the Company had 148,226,874 shares of common stock issued and outstanding and entitled to be voted at the Annual Meeting.  Two proposals were submitted to the Company’s shareholders at the Annual Meeting.  The proposals are described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on August 11, 2026.  The final voting results were as follows:

 

Proposal 1

 

The Company’s shareholders elected the following Class I Director to serve for a term expiring at the 2029 annual meeting.  The voting results are set forth below. 

 

 

Votes For

Votes Against

Votes Withheld

Broker Non-Vote

Jeffrey L. Parker

21,862,556

0

837,457

71,479,395

 

 

The Company's shareholders also elected the following Class II Director to serve for the remaining Class II term expiring at the 2027 annual meeting.

 

 

Votes For

Votes Against

Votes Withheld

Broker Non-Vote

Anthony B. Bowers

22,063,764

0

636,249

71,479,395

 

Proposal 2

 

The Company’s shareholders ratified the selection of Frazier & Deeter, LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2026.  The voting results are set forth below.

 

Votes For

Votes Against

Votes Abstained

Broker Non-Vote

93,703,944

51,229

424,235

N/A

 

 

 Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit

Description

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

Dated: September 28, 2026

   
   

PARKERVISION, INC.

     
   

By /s/ Cynthia French

   

Cynthia French

   

Chief Financial Officer

 

 

Keep reading